Physician profile
Karabeth B Moore
NPI 1396875118
$1,780.03
in general payments reported to CMS, 2019-2025
13 companies · $23.99 in 2025
The $23.99 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $86.78 · 2021: $71.17 · 2022: $124 · 2023: $45.72 · 2024: $1,267 · 2025: $23.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829 · Travel and Lodging: $481 · Entertainment: $27.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.95 |
| Travel and Lodging | $480.97 |
| Entertainment | $27.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $540.97 | 2024 | Biozorb, Localizer |
| Kub Technologies INC. | $283.75 | 2023-2024 | Mozart |
| Davol INC. | $242.04 | 2019-2022 | |
| Elucent Medical | $172.44 | 2024 | |
| Novartis Pharmaceuticals Corporation | $136.73 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $114.20 | 2023-2024 | Exparel |
| Sirius Medical Systems | $108.25 | 2024 | Pintuition |
| Merit Medical Systems INC | $73.40 | 2020-2024 | Savi Scout |
| Hologic Sales and Service, LLC | $47.54 | 2024 | Localizer |
| Innocoll Pharmaceuticals Limited | $16.36 | 2022 | |
| Stryker Corporation | $15.30 | 2024 | Eikon, Spy-Phi System |
| W. L. Gore & Associates, INC. | $15.05 | 2022 | |
| Boston Scientific Corporation | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karabeth Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.